Survey data shows individuals are not informed on how COVID-19 could affect their conditions.
Jeremy Edwards
Advertisement
Articles by Jeremy Edwards
87% of people surveyed said they had no concerns about a decentralized approach to clinical trials.
Advertisement
Latest Updated Articles
Rare Disease Patients Overlooked During COVIDJune 7th 2021
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When the Slack Runs Out: AI and the CRO Operating Model
2
Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations
3
What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed
4
ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment
5